Research programme: TAM inhibitors - SignalChem Lifesciences
Alternative Names: AXL inhibitors - SignalChem Lifesciences; TAM Inhibitors - SignalChem LifesciencesLatest Information Update: 28 Mar 2023
At a glance
- Originator SignalChem Lifesciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Axl receptor tyrosine kinase inhibitors; Proto-oncogene protein c-mer inhibitors; TYRO3 receptor protein tyrosine kinase antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Mar 2023 No recent reports of development identified for research development in Cancer in Canada